Global Oncology Pipeline Lead, Medical Affairs

ABBVIE; Florham Park (NJ); Hybrid; USD 188,000 - 505,000; Full time

Benefits offered by this job

Long-term incentive programs

Comprehensive benefits package

Job summary

AbbVie is seeking Head of Global Oncology Pipeline, Medical Affairs, a senior leader responsible for shaping the oncology portfolio and evidence strategy worldwide. This role requires directing a cross-functional team, aligning US and international markets, and collaborating with development, regulatory, and commercial partners in a hybrid work model with travel up to 25–30%.

The candidate should have extensive oncology/hematology experience and a strong track record in medical affairs

Qualifications

• MD or equivalent advanced degree in a relevant scientific discipline (oncology/hematology).
• 15+ years of experience in the pharmaceutical/biotech industry with a focus on oncology/hematology.
• Proven leadership experience in medical affairs, including managing teams and cross-functional collaboration.
• Strong scientific knowledge of solid tumor biology, clinical trial design, and biomarker development.

Responsibilities

• Lead global pipeline medical affairs strategy and develop differentiation across lifecycle.
• Direct pipeline execution team and ensure strategy pull-through to enterprise MSLs.
• Interface with Operations and Medical Engagement teams to operationalize pipeline strategy.
• Represent TA in pipeline governance and serve as the single point of contact for teams.
• Manage pipeline resources and handover to launch teams across geographies.

Skills

Leadership experience

Medical affairs

Cross-functional collaboration

Strategic communication

Education

MD or equivalent advanced degree

Job description

AbbVie is seeking Head of Global Oncology Pipeline, Medical Affairs, a senior leader responsible for shaping the oncology portfolio and evidence strategy worldwide. This role requires directing a cross-functional team, aligning US and international markets, and collaborating with development, regulatory, and commercial partners in a hybrid work model with travel up to 25–30%.

The candidate should have extensive oncology/hematology experience and a strong track record in medical affairs